Elevance Health Inc. (ELV)
NYSE: ELV
· Real-Time Price · USD
316.04
4.04 (1.29%)
At close: Aug 20, 2025, 9:48 AM
Elevance Health Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.27B | 2.18B | 413M | 1.01B | 2.3B | 2.25B | 831M | 1.3B | 1.86B | 2B | 961M | 1.61B | 1.63B | 1.79B | 1.13B | 1.5B | 1.8B | 1.67B |
Depreciation & Amortization | 360M | 373M | 398M | 329M | 335M | 331M | 424M | 426M | 433M | 462M | 473M | 451M | 393M | 358M | 360M | 351M | 309M | 282M |
Stock-Based Compensation | 90M | 81M | -29M | 66M | 92M | 62M | 72M | 78M | 78M | 61M | 73M | 69M | 72M | 50M | 59M | 63M | 69M | 64M |
Other Working Capital | -87M | 437M | 2.22B | -237M | -1.45B | -731M | -4.28B | -1.35B | -585M | 4.04B | -2.9B | 2.81B | -578M | 1.37B | 1.38B | 119M | 88M | 1.47B |
Other Non-Cash Items | -460M | 338M | -1.47B | 256M | -155M | 191M | 299M | 567M | 164M | 143M | 129M | 11M | 126M | -22M | -547M | -67M | -373M | -104M |
Deferred Income Tax | 80M | -174M | -116M | -224M | -170M | 136M | -241M | 32M | -138M | -255M | 94M | 2M | -85M | -92M | 59M | 122M | -39M | 31M |
Change in Working Capital | -291M | -1.78B | 1.51B | 1.24B | -1.96B | -988M | -4.36B | 210M | -443M | 4.05B | -3.25B | 2.78B | 312M | 452M | 616M | 533M | -84M | 565M |
Operating Cash Flow | 2.05B | 1.02B | 706M | 2.68B | 447M | 1.98B | -2.97B | 2.61B | 1.95B | 6.47B | -1.52B | 4.92B | 2.45B | 2.54B | 1.67B | 2.5B | 1.68B | 2.5B |
Capital Expenditures | -267M | -196M | -322M | -332M | -323M | -279M | -326M | -319M | -350M | -301M | -298M | -305M | -295M | -254M | -340M | -258M | -285M | -204M |
Cash Acquisitions | 50M | 4M | -3.72B | n/a | 395M | -1.12B | 18M | 81M | -13M | -1.64B | -26M | -14M | -548M | -61M | -34M | n/a | -3.42B | -27M |
Purchase of Investments | -4.14B | -3.96B | -3.28B | -4.67B | -3.93B | -6.1B | 8.1B | -6.69B | -10.21B | -7.44B | -5.33B | -6.36B | -8.2B | -5.05B | -3.54B | -3.91B | -4.24B | -6.98B |
Sales Maturities Of Investments | 3.86B | 4.57B | 5.48B | 4.47B | 3.19B | 5.43B | -8.82B | 6.37B | 9.97B | 6.02B | 5.6B | 5.52B | 7.23B | 4.26B | 2.89B | 3.14B | 2.94B | 5.65B |
Other Investing Acitivies | -189M | -315M | 205M | 130M | -145M | -241M | 3M | -126M | -77M | 176M | 347M | -90M | -209M | -469M | 61M | -409M | 75M | -746M |
Investing Cash Flow | -687M | 103M | -1.64B | -401M | -818M | -2.31B | -1.03B | -687M | -672M | -3.18B | 289M | -1.25B | -2.02B | -1.58B | -966M | -1.44B | -4.92B | -2.31B |
Debt Repayment | 195M | -819M | 3.82B | -358M | 1.34B | 764M | 861M | -288M | -534M | 700M | 945M | -474M | 584M | 740M | 186M | -500M | 137M | 3.21B |
Common Stock Repurchased | -378M | -880M | -1.81B | -60M | -463M | -566M | -928M | -480M | -646M | -622M | -568M | -579M | -624M | -545M | -522M | -451M | -480M | -447M |
Dividend Paid | -385M | -386M | -373M | -378M | -378M | -379M | -346M | -348M | -350M | -351M | -305M | -306M | -309M | -309M | -273M | -276M | -278M | -277M |
Other Financial Acitivies | 260M | 176M | -227M | -119M | 172M | 213M | 19M | 122M | 100M | -258M | -330M | 104M | 222M | 436M | -706M | 397M | -199M | 900M |
Financial Cash Flow | -308M | -1.91B | 1.41B | -915M | 668M | 32M | -394M | -994M | -1.43B | -531M | -258M | -1.25B | -127M | 322M | -1.31B | -830M | -820M | 3.39B |
Net Cash Flow | 1.06B | -788M | 422M | 1.37B | 271M | -300M | -4.39B | 928M | -151M | 2.75B | -1.49B | 2.42B | 295M | 1.28B | -610M | 232M | -4.07B | 3.58B |
Free Cash Flow | 1.79B | 821M | 384M | 2.35B | 124M | 1.7B | -3.3B | 2.29B | 1.6B | 6.17B | -1.82B | 4.62B | 2.16B | 2.29B | 1.33B | 2.25B | 1.4B | 2.3B |